EUVIMEDOpdag EUVIMED
Crossref

Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy

Hongna Ma, Chenxin Lu, Zhaoying Jin, Rui Liu, Zhaohua Miao iD, Zhengbao Zha iD, Zhenchao Tao

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c02550 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Hongna Ma and 6 co-authors. Institution: School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, People's Republic of China. Major MEDLINE topics: Rhodium, Alloys, Mice, Inbred BALB C, Photothermal Therapy. Cited 16 times so far (Crossref); 59 references. Funded by: Hefei National Research Center for Physical Sciences at the Microscale, Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Analogous to thermal ablation techniques in clinical settings, cell necrosis induced during tumor photothermal therapy (PTT) can provoke an inflammatory response that is detrimental to the treatment of tumors. In this study, we employed a straightforward one-step liquid-phase reduction process to synthesize uniform RhRe nanozymes with an average hydrodynamic size of 41.7 nm for non-inflammatory photothermal therapy. The obtained RhRe nanozymes showed efficient near-infrared (NIR) light absorption for effective PTT, coupled with a remarkable capability to scavenge reactive oxygen species (ROS) for anti-inflammatory treatment. After laser irradiation, the 4T1 tumors were effectively ablated without obvious tumor recurrence within 14 days, along with no obvious increase in pro-inflammatory cytokine levels. Notably, these RhRe nanozymes demonstrated high biocompatibility with normal cells and tissues, both in vitro and in vivo, as evidenced by the lack of significant toxicity in female BALB/c mice treated with 10 mg/kg of RhRe nanozymes over a 14 day period. This research highlights RhRe alloy nanoparticles as bioactive nanozymes for non-inflammatory PTT in tumor therapy.

Subjects

MeSH terms (MEDLINE)

RhodiumAlloysMice, Inbred BALB CPhotothermal TherapyRheniumAnimalsMiceFemaleCell Line, TumorHumansReactive Oxygen Species

Author keywords

anti-inflammatorynanozymephotothermal therapyreactive oxygen speciestumor ablation

Substances

RhodiumAlloysRheniumReactive Oxygen Species

Authors and institutions

  • School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, People's Republic of China.
  • Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China.
  • Department of Radiation Oncology, The First Affiliated Hospital of USTC West District, Anhui Provincial Cancer Hospital, Hefei, Anhui 230031, People's Republic of China.
  • Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, People's Republic of China.

ORCID profiles: Zhaohua Miao, Zhengbao Zha

Funding

  • Hefei National Research Center for Physical Sciences at the Microscale
  • Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education

Cite

APA

Ma, H., Lu, C., Jin, Z., Liu, R., Miao, Z., Zha, Z., & Tao, Z. (2024). Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c02550

Vancouver

Ma H, Lu C, Jin Z, Liu R, Miao Z, Zha Z, et al. Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c02550

BibTeX
@article{Ma2024,
  author = {Ma, Hongna and Lu, Chenxin and Jin, Zhaoying and Liu, Rui and Miao, Zhaohua and Zha, Zhengbao and Tao, Zhenchao},
  title = {Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c02550}
}
Start for free →